Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Other Proteins

Recombinant ZIKV Protein prM/prM Protein, N-GST & C-His (VK498012)

Price(USD): $
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview
  • Images
  • References
  • Datasheet
Overview
Catalog No.VK498012
Expression systemE. coli
AccessionQ32ZE1
Protein lengthSer130-Arg215
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesZika virus (ZIKV)
NatureRecombinant
Endotoxin levelPlease contact with the lab for this information.
Purity>90% as determined by SDS-PAGE.
Predicted molecular weight37.91 kDa
FormLyophilized
Storage bufferLyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
ReconstitutionReconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
ShippingIn general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and StorageUse a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesGenome polyprotein, Capsid protein C, Capsid protein, Core protein, Protein prM, Precursor membrane protein, Peptide pr, Peptide precursor, Small envelope protein M, Matrix protein, Envelope protein E, Non-structural protein 1, NS1, Non-structural protein 2A, NS2A, Serine protease subunit NS2B, Flavivirin protease NS2B regulatory subunit, Non-structural protein 2B, Serine protease NS3, 3.4.21.91, 3.6.1.15, 3.6.4.13, Flavivirin protease NS3 catalytic subunit, Non-structural protein 3, Non-structural protein 4A, NS4A, Peptide 2k, Non-structural protein 4B, NS4B, RNA-directed RNA polymerase NS5, 2.1.1.56, 2.1.1.57, 2.7.7.48, NS5
Background

Zika virus (ZIKV) is an arthropod-borne flavivirus transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes. Closely related to dengue and yellow fever viruses, ZIKV was first discovered in Uganda in 1947. While most infections cause mild fever, rash, and conjunctivitis, major outbreaks in the Americas revealed strong links to Guillain–Barré syndrome in adults and congenital Zika syndrome in newborns, including microcephaly and other neurological defects.

At the molecular level, ZIKV is a positive-sense single-stranded RNA virus, encoding both structural proteins (C, prM, E) and non-structural proteins (NS1–NS5). These viral proteins play central roles in viral replication, immune evasion, and host-pathogen interactions, making them key research targets. Two major lineages—African and Asian—have been identified, with the Asian lineage responsible for large-scale epidemics in the Pacific and the Americas.

With no licensed vaccine or antiviral therapy available, ZIKV remains a priority in global virology and immunology research. abinScience supports scientists by providing high-quality ZIKV antibodies, recombinant proteins, and assay solutions to accelerate discoveries in pathogenesis, diagnostics, and therapeutic development.

NoteFor research use only.
Images
  • SDS-PAGE

    SDS-PAGE for Recombinant ZIKV Protein prM/prM Protein, N-GST & C-His

Recommendation